Our Co-Founder & CCA Leonie van de Kamer starring at the LSI Event in Barcelona last September!

In the picture she is showing the world's smallest endoscope developed together with OptaSensor GmbH to enhance placement of the Choice devices in the fallopian tubes and to prevent adverse events during placement.

What we did with the sheep & cow fallopian tubes, we repeated inside human fallopian tubes. Marlies Bongers & Bas Veersema, our gynaecologists from our Board of Advice went inside two  just removed uterusses. We learned a lot, but unfortunately after the session our images were corrupted #$@!!. The ampulla, where fertilization takes place & so we have all began, looks pretty similar as the previous video of a sheep's ampulla. We will do this again!

With our newly developed tools we are exploring where all of us began...Together with the UMC professors Bas Veersema (Gynaecology) & Peter Vos (Veterinary Medicine) we looked inside cow & sheep fallopian tubes (this is a sheep). Human fallopian tubes to follow soon.

Peter van de Graaf presented Choice to some 100 female students at Sohag University, followed by a lively discussion. Overall outcome was that most students considered Choice excellent contraception for themselves and Egypt in general, as we have found elsewhere. We must reach the poor, whose needs are highest because of their large families, leading to rapid population increase in Egypt. For this Choice will need social workers for outreach, and, most important, Choice needs to be affordable.

With regard to cultural issues: the family planning decisions are not an individual decision, but take place within the (extended) family, and because sterilization is religiously contentious it should not be labelled "reversible sterilization".

Thanks a bundle to Sohag University, Laila El-Sayed & my brother in law Samir Khalifa for making this extraordinary and interesting session possible.

We are happy to announce that we successfully passed our first ISO 13485 audit. This will lead to a ISO certification expected Q1 2023. This is an important step for Choice as this ISO certificate will help us grow within the medical device business (work together with suppliers and eventually customers) and will help the company to maintain a solid and respected quality management system from design and development stages until post-marketing.